品牌咨询
联系方式
公司地址
苏州工业园区生物纳米园A4#216
联系电话
4000-520-616 / 18915418616
传真号码
0512-67156496
电子邮箱
info@ebiomall.com
公司网址
https://www.ebiomall.com

PBL/Human IFN Alpha D (Alpha 1)/1 x 105 units/11125-1

价格
¥5600.00
货号:11125-1
浏览量:127
品牌:pblassaysci
服务
全国联保
正品保证
正规发票
签订合同
商品描述

Human IFN Alpha D (Alpha 1)

Product Features:
  • Human IFN Alpha 1 recombinant protein expressed in E.coli
  • Expression is induced by viral infection
  • Encoding gene IFNA1 at position Val114

Ordering

Catalog No. Pack Size Price Quantity
11125-1

1 x 105 units

$280.00
  • Specifications
  • Tech Info / Data
  • Citations
  • Documentation

Specifications

FormulationSupplied frozen in phosphate-buffered saline (PBS) containing 0.1% Bovine Serum Albumin (BSA)
Molecular Weight19.4 kDa
SourcecDNA obtained from human leukocyte mRNA expressed in E.coli
Purity> 95% by SDS-PAGE stained by Coomassie Blue 
BioactivityMeasured using a cytopathic inhibition assay on Bovine Kidney Cells (MDBK) with Vesicular Stomatis Virus (VSV); human lung carcinoma cell line A549 with encephalomyocarditis virus (EMCV)
StorageFor retention of full activity store at -70 ºC or below and avoid repeated freeze-thaw cycles
SynonymsHu-[Val114] IFN-α1 
Accession NumberV00538

Tech Info / Data

Background:

Recombinant Human Interferon Alpha D (Hu-IFN-alpha D; Hu-[Val114] IFN-alpha 1) obtained from human leukocyte mRNA expressed in E.coli.


IFN alpha 1 is one of the many interferon alpha subtypes belonging to the Type I leukocyte IFN family. The Type I IFN family has antiviral, anti-proliferative and natural killer cell activities.

Citations

Documentation

Human IFN Alpha D (Alpha 1) Titration in A549

Titration of Human Interferon Alpha D (Alpha 1) in the A549 Cell Line
PBL分析开发服务可以根据您的特定需求量身定制。分析方法被开发用于研究用途或支持后续GLP验证的标准。 您可以确信,PBL将提供可行的解决方案,从而在开发项目期间最大程度地提高您样本中的数据。我们将与您一起确定必要的步骤,所需的试剂并在潜在问题发生之前确定它们。从原理证明到技术转让,我们的经验将确保我们为您的特定应用需求提供强大而灵敏的测定解决方案。 基于细胞的分析开发 提供但不限于基于细胞的分析开发服务,包括:定制的细胞病变作用,抗增殖和生长促进测定开发报告基因系统或鉴定细胞系以监测目标化合物的活性抗体对生物活性的中和,与鉴定生物活性单克隆抗体(MAb)和监测免疫原性有关免疫分析开发 定制的免疫测定和ELISA支持:药代动力学和药效学研究毒性和免疫原性研究直接,夹心或竞争性ELISA分析开发分析优化服务 特异性和交叉反应性评估分析和动态范围优化减少基质效应(血清,血浆,组织培养基)减少批内和批内变异性标准校准分析稳定性评估协议优化